TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/23 12:26 | 9/22/23 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | A1 | D | P | 98 | 4.91 | 0 | 20 | 1 | 1,442 | I | |||||||||||||||
8/9/23 12:22 | 8/8/23 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | A1 | D | P | 177 | 5.90 | 0 | 30 | 2 | 1,422 | I | |||||||||||||||
3/30/23 16:26 | 3/30/22 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | CA | D | P.m | 1,078 | 12.28 | 0 | 88 | 161 | 142 | I | |||||||||||||||
12/17/20 20:30 | 12/15/20 | ABCL | Abcellera Biologics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | A1 | D | P.d | 1,473 | 20.00 | 0 | 74 | 6 | 1,222 | I | |||||||||||||||
11/13/19 19:02 | 11/11/19 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | CA | D | P.d | 300 | 16.00 | 0 | 19 | 32 | 78 | I | |||||||||||||||
8/14/17 18:06 | 8/14/17 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Hayden Michael R | A1 | D | P | 41 | 2.75 | 0 | 15 | 6 | 267 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |